Total Neo-adjuvant therapy

DRUG2 trials

Sponsors

AHS Cancer Control Alberta, Sichuan Huiyang Life Science and Technology Corporation

Conditions

Mid-low Locally Advanced Rectal CancerRectal Cancer

Phase 2

PET/MRI in Rectal Cancer

Not yet recruitingNCT06057831

AHS Cancer Control AlbertaRectal Cancer

Start: 2026-05-31End: 2030-12-31Target: 40Updated: 2025-06-18

rSIFN-co in Combination With Total Neo-adjuvant Therapy in Subjects With Mid-low Locally Advanced Rectal Cancer

Not yet recruitingNCT07662278

Sichuan Huiyang Life Science and Technology CorporationMid-low Locally Advanced Rectal Cancer

Start: 2027-01-01End: 2030-06-01Target: 90Updated: 2026-06-23